Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammationKarly C. Sourris, Melinda T. Coughlan, Simon Crawford et al.|Kidney International|2023Cited by 121
RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to ApoptosisShinji Hagiwara, Phillip Kantharidis, Mark Ziemann et al.|Diabetes|2018Cited by 22